Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary M Ansel

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Circulation|October 7, 2017
Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)Ido Weinberg, Joshua A Beckman, Jon S Matsumura, et al.
Cardiovascular and Interventional Radiology|September 11, 2019
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated DevicesMichael D Dake, Gary M Ansel, Marc Bosiers, et al.
Circulation|June 21, 2017
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) InitiativeConnie N Hess, Lars Norgren, Gary M Ansel, et al.
Circulation|March 13, 2016
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized TrialMichael D Dake, Gary M Ansel, Michael R Jaff, et al.
Vascular and Endovascular Surgery|October 23, 2020
Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery DiseaseE Hope Weissler, Dennis I Narcisse, Jennifer A Rymer, et al.
American Heart Journal|June 22, 2015
The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspectiveNevin C Baker, Gary M Ansel, Sunil V Rao, et al.
Circulation|October 1, 2019
Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 YearsWilliam A Gray, Michael R Jaff, Sahil A Parikh, et al.
Clinical Cardiology|August 12, 2020
The impact of chronic kidney disease on outcomes following peripheral vascular interventionDennis I Narcisse, Elizabeth Hope Weissler, Jennifer A Rymer, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 2, 2013
Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trialRichard R Saxon, Arun Chervu, Paul A Jones, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 3, 2018
Design Strategies for Global Clinical Trials of Endovascular Devices for Critical Limb Ischemia (CLI)　- A Joint USA-Japanese PerspectiveHiroyoshi Yokoi, Mami Ho, Shin Iwamoto, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Circulation|October 7, 2017
Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)Ido Weinberg, Joshua A Beckman, Jon S Matsumura, et al.
Cardiovascular and Interventional Radiology|September 11, 2019
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated DevicesMichael D Dake, Gary M Ansel, Marc Bosiers, et al.
Circulation|June 21, 2017
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) InitiativeConnie N Hess, Lars Norgren, Gary M Ansel, et al.
Circulation|March 13, 2016
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized TrialMichael D Dake, Gary M Ansel, Michael R Jaff, et al.
Vascular and Endovascular Surgery|October 23, 2020
Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery DiseaseE Hope Weissler, Dennis I Narcisse, Jennifer A Rymer, et al.
American Heart Journal|June 22, 2015
The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspectiveNevin C Baker, Gary M Ansel, Sunil V Rao, et al.
Circulation|October 1, 2019
Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 YearsWilliam A Gray, Michael R Jaff, Sahil A Parikh, et al.
Clinical Cardiology|August 12, 2020
The impact of chronic kidney disease on outcomes following peripheral vascular interventionDennis I Narcisse, Elizabeth Hope Weissler, Jennifer A Rymer, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 2, 2013
Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trialRichard R Saxon, Arun Chervu, Paul A Jones, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 3, 2018
Design Strategies for Global Clinical Trials of Endovascular Devices for Critical Limb Ischemia (CLI)　- A Joint USA-Japanese PerspectiveHiroyoshi Yokoi, Mami Ho, Shin Iwamoto, et al.
Pageof 8